Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine.

Literature DB >> 34341492

Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine.

Chadi G Abdallah^1,2,3,4,5, Graeme F Mason^6,7.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2022 PMID： 34341492 PMCID： PMC8617283 DOI： 10.1038/s41386-021-01122-2

Source DB: PubMed Journal: Neuropsychopharmacology ISSN： 0893-133X Impact factor: 7.853

× No keyword cloud information.

6 in total

1. Ketamine Treatment and Global Brain Connectivity in Major Depression.

Authors: Chadi G Abdallah; Lynnette A Averill; Katherine A Collins; Paul Geha; Jaclyn Schwartz; Christopher Averill; Kaitlin E DeWilde; Edmund Wong; Alan Anticevic; Cheuk Y Tang; Dan V Iosifescu; Dennis S Charney; James W Murrough
Journal: Neuropsychopharmacology Date: 2016-09-08 Impact factor: 7.853

Review 2. In vivo ¹³ C and ¹ H-[¹³ C] MRS studies of neuroenergetics and neurotransmitter cycling, applications to neurological and psychiatric disease and brain cancer.

Authors: Douglas L Rothman; Robin A de Graaf; Fahmeed Hyder; Graeme F Mason; Kevin L Behar; Henk M De Feyter
Journal: NMR Biomed Date: 2019-09-02 Impact factor: 4.044

3. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.

Authors: Chadi G Abdallah; Henk M De Feyter; Lynnette A Averill; Lihong Jiang; Christopher L Averill; Golam M I Chowdhury; Prerana Purohit; Robin A de Graaf; Irina Esterlis; Christoph Juchem; Brian P Pittman; John H Krystal; Douglas L Rothman; Gerard Sanacora; Graeme F Mason
Journal: Neuropsychopharmacology Date: 2018-06-28 Impact factor: 7.853

1 in total

Review 1. Imaging synaptic density in depression.

Authors: Sophie E Holmes; Chadi Abdallah; Irina Esterlis
Journal: Neuropsychopharmacology Date: 2022-06-29 Impact factor: 7.853

1 in total

Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine.

1. Ketamine Treatment and Global Brain Connectivity in Major Depression.

Review 2. In vivo ¹³ C and ¹ H-[¹³ C] MRS studies of neuroenergetics and neurotransmitter cycling, applications to neurological and psychiatric disease and brain cancer.

3. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.

Review 4. Synaptic dysfunction in depression: potential therapeutic targets.

5. Glutamate metabolism in major depressive disorder.

6. Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects.

Review 1. Imaging synaptic density in depression.

Novel approaches to estimate prefrontal synaptic strength in vivo in humans: of relevance to depression, schizophrenia, and ketamine.

1. Ketamine Treatment and Global Brain Connectivity in Major Depression.

Review 2. In vivo 13 C and 1 H-[13 C] MRS studies of neuroenergetics and neurotransmitter cycling, applications to neurological and psychiatric disease and brain cancer.

3. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.

Review 4. Synaptic dysfunction in depression: potential therapeutic targets.

5. Glutamate metabolism in major depressive disorder.

6. Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects.

Review 1. Imaging synaptic density in depression.

Review 2. In vivo ¹³ C and ¹ H-[¹³ C] MRS studies of neuroenergetics and neurotransmitter cycling, applications to neurological and psychiatric disease and brain cancer.